Health-Related quality of life and quality of life in type 2 diabetes: Relationships in a cross-sectional study

Patient

Volumn 2, Issue 2, 2009, Pages 121-133

  Sundaram, Murali ^a,c   Kavookjian, Jan ^b   Patrick, Julie Hicks ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

^c QualityMetric Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; DIET; DISEASE ASSOCIATION; DISEASE DURATION; ELECTRONIC MEDICAL RECORD; FEMALE; GLYCEMIC CONTROL; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 77149140314     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/01312067-200902020-00008     Document Type: Article

References (52)

1. Polonsky WH. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 2000; 13 (1): 36-41
2. Rothman ML, Beltran P, Cappelleri JC, et al. Patient-reported outcomes: conceptual issues. Value Health 2007; 10 Suppl. 2: S66-75
3. Health and Quality of Life Outcomes. Guidance for in dustry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006; 4: 79 [online]. Available from URL http://www.hqlo.com/content/4/1/79 [Accessed 2006 Dec 5]
4. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17 (4): 267-74
5. Anderson RM, Fitzgerald JT, Wisdom K, et al. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997; 20 (3): 299-305
6. Gandhi GY, Murad MH, Fujiyoshi A, et al. Patient-important outcomes in registered diabetes trials. JAMA 2008; 299 (21): 2543-9
7. Rubin RR. Diabetes and quality of life. Diabetes Spectrum 2000; 13 (1): 21-3
8. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28 (11): 2668-72
9. Kleefstra N, Landman GW, Houweling ST, et al. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care 2008; 31 (5): 932-3
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329 (14): 977-86
11. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet 1998; 352 (9131): 837-53
12. The Diabetes Control and Complications Trial Research Group. Influence ofintensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996; 19 (3): 195-203
13. United Kingdom Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999; 22 (7): 1125-36
14. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001; 357 (9249): 7-8
15. Speight J. Assessing the impact of diabetes screening on quality of life or quality of health? Semantics are important. Diabetes Care 2002; 25 (10): 1893-4
16. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37 (1): 53-72
17. Kind P. The EuroQoL instrument: an index of health-related quality of life. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia (PA): Lippincott-Raven, 1996: 191-201
18. Bradley C, Todd C, Gorton T, et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8 (1-2): 79-91
19. Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review.Diabet Med 2002; 19 (1): 1-11
20. Wildes KR, Greisinger A, O'Malley KJ. Critical review of quality of life measures for patients with diabetes: Report of the measurement excellence initiative. 2003. 1-17-2004 [online]. Available from URL: http://www.measurement experts.org/criticalReview.htm. [Accessed 2004 Jan 17]
21. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35 (11): 1095-108
22. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005; 43 (3): 203-20
23. Ware Jr J, Kosinski M, Keller SD, et al. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34 (3): 220-33
24. Ware Jr J, Kosinski M, Turner-Bowker DM, et al. How to score Version 2 of the SF-12® Health Survey (with a supplement documenting Version 1). Lincoln (RI): Quality- Metric Inc., 2002
25. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15 (3): 205-18
26. Nerenz DR, Repasky DP, Whitehouse FW, et al. Ongoing assessment of health status in patients with diabetes melli- tus. Med Care 1992; 30 (5 Suppl.): MS112-24
27. Glasgow RE, Ruggiero L, Eakin EG, et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997; 20 (4): 562-7
28. de Sonnaville JJ, Snoek FJ, Colly LP, et al. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care 1998; 21 (6): 919-24
29. Sundaram M, Kavookjian J, Patrick JH, et al. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res 2007; 16 (2): 165-77
30. Ford ES, Moriarty DG, Zack MM, et al. Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System. Obes Res 2001; 9(1): 21-31
31. Hassan MK, Joshi AV, Madhavan SS, et al. Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes Relat Metab Disord 2003; 27 (10): 1227-32
32. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000; 23 (10): 1556-62
33. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence,function, and costs. Arch Intern Med 2000; 160 (21): 3278-85
34. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401
35. Weissman MM, Sholomskas D, Pottenger M, et al. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977; 106 (3): 203-14
36. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28 Suppl. 1: S4-36
37. Centers for Disease Control and Prevention. BMI-body mass index [online]. Available from URL: http://www.cdc.gov/nccdphp/dnpa/bmi/index.htm. [Accessed 2004 Dec 15]
38. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5):373-83
39. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996; 49 (12):1429-33
40. Arbuckle JL. Amos (version 4.0) [computer program]. Chicago (IL): Smallwaters Corporation, 1999
41. Byrne BM. Structural equation modeling with AMOS.Mahwah (NJ): Erlbaum, 2001
42. SPSS for Windows Release 14 [computer program]. Chicago (IL): SPSS Inc., 2004
43. Sullivan M. The new subjective medicine: taking the patient's point of view on health care and health. Soc Sci Med 2003; 56 (7): 1595-604
44. Ware Jr JE, Kosinski M, Bjorner JB, et al. User's manual for the SF-36 Health Survey (version 2). 2nd ed. Lincoln (RI):QualityMetric Inc., 2006
45. Ware Jr JE, Kosinski M, Bjorner JB, et al. User's manual for the SF-36v2 Health Survey. 2nd ed. Lincoln (RI):QualityMetric Inc., 2007
46. Muntaner C, Barnett E. Depressive symptoms in rural West Virginia: labor market and health services correlates. J Health Care Poor Underserved 2000; 11 (3):284-300
47. Hanninen J, Takala J, Keinanen-Kiukaanniemi S.Quality of life in NIDDM patients assessed with the SF-20 questionnaire. Diabetes Res Clin Pract 1998; 42 (1): 17-27
48. Davis TM, Clifford RM, Davis WA. Effect of insulin ther apy on quality of life in type 2 diabetes mellitus: the Fre- mantle Diabetes Study. Diabetes Res Clin Pract 2001; 52 (1): 63-71
49. Ristic S, Bates PC. Effects ofrapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus. Diabetes Technol Ther 2003; 5 (1): 57-66
50. Zhang X, Norris SL, Chowdhury FM, et al. The effects of interventions on health-related quality of life among persons with diabetes: a systematic review. Med Care 2007;45 (9): 820-34
51. Vinik AI, Zhang Q. Adding insulin glargine versus rosigli-tazone: health-related quality-of-life impact in type 2 diabetes. Diabetes Care 2007; 30 (4): 795-800
52. Bradley C. Feedback on the FDA's February 2006 draft guidance on patient reported outcome (PRO) measures from a developer of PRO measures. Health Qual Life Outcomes 2006; 4: 78 [online]. Available from URL: http://www.hqlo.com/ content/4/1/78 [Accessed 2006 Dec 5]